768 Systemic delivery of a tumor-targeted TLR9 agonist conjugate transforms the tumor immune landscape and induces tumor regression in mice by Idit Sagiv-Barfi, Ronald Levy, Caitlyn Miller Candidate, Patrick Neuhoefer, Debra Czerwinski, Steven Artandi, Carolyn Bertozzi, Jennifer Cochran